Rezatapopt: A promising small-molecule "refolder" specific for TP53Y220C mutant tumors
{{output}}
Inactivation of p53 due to mutation is observed in approximately half of all human cancer cases, therefore, restoration of the tumor suppressor function of oncogenic p53 mutants represents an attractive and rational therapeutic approach. Currently, multiple mu... ...